Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Happel David
President & CEO at Sagimet Biosciences. Filing since 16 Nov 2023.
CIK 0001623567
Company
Date
Role
Action
Shares
Amount
Of holding
SGMT
Sagimet Biosciences Inc.
20 Jul 2026
President & CEO
Sold at will
64,051
$497.07K
8.0%
SGMT
Sagimet Biosciences Inc.
10 Feb 2026
President & CEO
Sold at will
12,101
$64.86K
1.8%
SGMT
Sagimet Biosciences Inc.
21 Jul 2025
President & CEO
Sold at will
65,478
$598.12K
8.7%
SGMT
Sagimet Biosciences Inc.
26 Mar 2024
President & CEO
Bought
12,100
$63.73K
1.9%
SGMT
Sagimet Biosciences Inc.
7 Dec 2023
President & CEO
Bought
1,600
$6.56K
0.3%
SGMT
Sagimet Biosciences Inc.
16 Nov 2023
President & CEO
Bought
590
$1.39K
opened
6 decisions on file.
